4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $576.76 million. The enterprise value is $240.14 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 56.38 million shares outstanding. The number of shares has increased by 22.87% in one year.
| Current Share Class | 56.38M |
| Shares Outstanding | 56.38M |
| Shares Change (YoY) | +22.87% |
| Shares Change (QoQ) | +2.82% |
| Owned by Insiders (%) | 2.68% |
| Owned by Institutions (%) | 84.47% |
| Float | 43.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.00 |
| Forward PS | 45.43 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.11.
| Current Ratio | 6.15 |
| Quick Ratio | 5.94 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.68% and return on invested capital (ROIC) is -34.84%.
| Return on Equity (ROE) | -56.68% |
| Return on Assets (ROA) | -31.36% |
| Return on Invested Capital (ROIC) | -34.84% |
| Return on Capital Employed (ROCE) | -56.85% |
| Weighted Average Cost of Capital (WACC) | 18.98% |
| Revenue Per Employee | $490,122 |
| Profits Per Employee | -$1.02M |
| Employee Count | 196 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.28% in the last 52 weeks. The beta is 2.91, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.91 |
| 52-Week Price Change | -5.28% |
| 50-Day Moving Average | 12.80 |
| 200-Day Moving Average | 11.12 |
| Relative Strength Index (RSI) | 37.50 |
| Average Volume (20 Days) | 909,461 |
Short Selling Information
The latest short interest is 10.90 million, so 19.33% of the outstanding shares have been sold short.
| Short Interest | 10.90M |
| Short Previous Month | 11.53M |
| Short % of Shares Out | 19.33% |
| Short % of Float | 24.80% |
| Short Ratio (days to cover) | 10.72 |
Income Statement
In the last 12 months, FDMT had revenue of $96.06 million and -$200.35 million in losses. Loss per share was -$2.92.
| Revenue | 96.06M |
| Gross Profit | -161.38M |
| Operating Income | -213.95M |
| Pretax Income | -200.35M |
| Net Income | -200.35M |
| EBITDA | -208.97M |
| EBIT | -213.95M |
| Loss Per Share | -$2.92 |
Full Income Statement Balance Sheet
The company has $375.03 million in cash and investments and $38.41 million in debt, with a net cash position of $336.62 million or $5.97 per share.
| Cash & Investments | 375.03M |
| Total Debt | 38.41M |
| Net Cash | 336.62M |
| Net Cash Per Share | $5.97 |
| Equity (Book Value) | 337.94M |
| Book Value Per Share | 5.99 |
| Working Capital | 269.89M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$166.28 million and capital expenditures -$34,000, giving a free cash flow of -$166.32 million.
| Operating Cash Flow | -166.28M |
| Capital Expenditures | -34,000 |
| Depreciation & Amortization | 4.98M |
| Net Borrowing | 19.26M |
| Free Cash Flow | -166.32M |
| FCF Per Share | -$2.95 |
Full Cash Flow Statement Margins
Gross margin is -167.99%, with operating and profit margins of -222.71% and -208.56%.
| Gross Margin | -167.99% |
| Operating Margin | -222.71% |
| Pretax Margin | -208.56% |
| Profit Margin | -208.56% |
| EBITDA Margin | -217.53% |
| EBIT Margin | -222.71% |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -22.87% |
| Shareholder Yield | -22.87% |
| Earnings Yield | -28.53% |
| FCF Yield | -28.84% |
Analyst Forecast
The average price target for FDMT is $28.09, which is 174.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.09 |
| Price Target Difference | 174.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -16.06% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of -0.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.08 |
| Piotroski F-Score | 2 |